You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Recent awards include:
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at S&P Capital IQ Pro or S&P Capital IQ .
Medtronic's neurosurgery guidance system receives US FDA clearance
Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud
Investment Research Analysts Providing Greater Coverage on Inflation
Using Credit Analytics to Avoid Mispricing Insurance Premiums
Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios
The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.
Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.
Dublin-based Medtronic develops device-based medical therapies.